SUSRF vs ABBV: Which Stock is Better?
Side-by-side comparison of Surgical Science Sweden AB (publ) and Abbvie Inc in 2026
SUSRF
Surgical Science Sweden AB (publ)
$2.84
ABBV
Abbvie Inc
$208.38
Key Metrics Comparison
| Metric | SUSRF | ABBV | Winner |
|---|---|---|---|
| Market Cap | $150.36M | $368.57B | ABBV |
| P/E Ratio | 20.29 | 87.55 | SUSRF |
| EPS (TTM) | $0.14 | $2.38 | ABBV |
| Revenue Growth | 0.1% | 0.1% | ABBV |
| Gross Margin | 66.6% | 71.6% | ABBV |
Analyze SUSRF
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SUSRF or ABBV a better investment?
Comparing SUSRF and ABBV: Surgical Science Sweden AB (publ) has a market cap of $150.36M while Abbvie Inc has $368.57B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SUSRF and ABBV?
SUSRF (Surgical Science Sweden AB (publ)) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SUSRF or ABBV?
Based on P/E ratios, SUSRF trades at a lower multiple (20.3x vs 87.6x).
Which is growing faster: SUSRF or ABBV?
ABBV has higher revenue growth at 0.1% vs 0.1% for SUSRF.
Which company is more profitable: SUSRF or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 66.6% for SUSRF.
Which is the larger company: SUSRF or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $368.57B compared to $150.36M for SUSRF.
Should I buy SUSRF or ABBV in 2026?
Both SUSRF and ABBV have investment merit. SUSRF trades at $2.84 while ABBV trades at $208.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SUSRF and ABBV stock?
Key differences: Market Cap ($150.36M vs $368.57B), P/E Ratio (20.3x vs 87.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (66.6% vs 71.6%).